Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma.

Hamilton DW, Lusher ME, Lindsey JC, Ellison DW, Clifford SC.

Cancer Lett. 2005 Sep 8;227(1):75-81. Epub 2004 Dec 25.

PMID:
16051033
2.

Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.

Lindsey JC, Lusher ME, Anderton JA, Bailey S, Gilbertson RJ, Pearson AD, Ellison DW, Clifford SC.

Carcinogenesis. 2004 May;25(5):661-8. Epub 2003 Dec 19.

3.

Aberrant CpG island methylation of multiple genes in ependymal tumors.

Alonso ME, Bello MJ, Gonzalez-Gomez P, Arjona D, de Campos JM, Gutierrez M, Rey JA.

J Neurooncol. 2004 Mar-Apr;67(1-2):159-65.

PMID:
15072463
4.

Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas.

Alonso ME, Bello MJ, Gonzalez-Gomez P, Arjona D, Lomas J, de Campos JM, Isla A, Sarasa JL, Rey JA.

Cancer Genet Cytogenet. 2003 Jul 15;144(2):134-42.

PMID:
12850376
5.

Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.

Michalowski MB, de Fraipont F, Michelland S, Entz-Werle N, Grill J, Pasquier B, Favrot MC, Plantaz D.

Cancer Genet Cytogenet. 2006 Apr 1;166(1):74-81.

PMID:
16616114
6.

Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.

Lusher ME, Lindsey JC, Latif F, Pearson AD, Ellison DW, Clifford SC.

Cancer Res. 2002 Oct 15;62(20):5906-11.

7.

Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors.

Michalowski MB, de Fraipont F, Plantaz D, Michelland S, Combaret V, Favrot MC.

Pediatr Blood Cancer. 2008 Jan;50(1):29-32.

PMID:
17570703
8.

Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.

Hesson L, Bi├Ęche I, Krex D, Criniere E, Hoang-Xuan K, Maher ER, Latif F.

Oncogene. 2004 Mar 25;23(13):2408-19.

PMID:
14743209
9.

Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas.

Yoshino A, Katayama Y, Ogino A, Watanabe T, Yachi K, Ohta T, Komine C, Yokoyama T, Fukushima T.

J Neurooncol. 2007 Jun;83(2):153-62. Epub 2007 Jan 11.

PMID:
17216555
10.

DNA methylation analysis of tumor suppressor genes in monoclonal gammopathy of undetermined significance.

Stanganelli C, Arbelbide J, Fantl DB, Corrado C, Slavutsky I.

Ann Hematol. 2010 Feb;89(2):191-9. doi: 10.1007/s00277-009-0818-3.

PMID:
19727727
11.

[Clinical significance of detection of tumor suppressor genes aberrant methylation in cervical carcinoma tissue].

Xu J, Wang HL, Lu GC, Wang ZJ, Lin X, Zhou HW.

Zhonghua Fu Chan Ke Za Zhi. 2007 Jun;42(6):394-7. Chinese.

PMID:
17697601
12.

The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.

Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T, Fukushima T.

J Neuropathol Exp Neurol. 2005 May;64(5):398-403.

13.

DNA hypermethylation status of multiple genes in soft tissue sarcomas.

Kawaguchi K, Oda Y, Saito T, Yamamoto H, Takahira T, Kobayashi C, Tamiya S, Tateishi N, Iwamoto Y, Tsuneyoshi M.

Mod Pathol. 2006 Jan;19(1):106-14.

14.

Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression.

Watanabe T, Katayama Y, Yoshino A, Yachi K, Ohta T, Ogino A, Komine C, Fukushima T.

Brain Pathol. 2007 Jan;17(1):5-10.

PMID:
17493032
15.
16.

Promoter methylation status of multiple genes in uveal melanoma.

Merhavi E, Cohen Y, Avraham BC, Frenkel S, Chowers I, Pe'er J, Goldenberg-Cohen N.

Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4403-6.

PMID:
17898258
17.

Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.

Furonaka O, Takeshima Y, Awaya H, Ishida H, Kohno N, Inai K.

Pathol Int. 2004 Aug;54(8):549-55.

PMID:
15260845
18.

Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.

Yang Q, Zage P, Kagan D, Tian Y, Seshadri R, Salwen HR, Liu S, Chlenski A, Cohn SL.

Clin Cancer Res. 2004 Dec 15;10(24):8493-500.

19.

Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.

Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.

Lung Cancer. 2007 Oct;58(1):131-8. Epub 2007 Jul 2.

PMID:
17606310
20.

Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.

Murao K, Kubo Y, Ohtani N, Hara E, Arase S.

Br J Dermatol. 2006 Nov;155(5):999-1005.

PMID:
17034532
Items per page

Supplemental Content

Write to the Help Desk